Effect of finerenone on renal function in patients with type 2 diabetic nephropathy: a retrospective cohort study

BackgroundDiabetic nephropathy (DN) remains a major cause of chronic kidney disease despite optimized renin–angiotensin system blockade. This study aimed to evaluate the efficacy and safety of adding finerenone to angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (ACEI/ARB) the...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xu-Ying Liu, Ya-Min Zhao, Ya-Guang Zhang, Yi Liu, Bo-Ya Wang, Zhen-Zhen Hao, Man-Hui Hu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-02-01
Series:	Frontiers in Endocrinology
Assuntos:	albuminuria chronic kidney disease diabetic nephropathies finerenone glomerular filtration rate
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fendo.2026.1753126/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!